Why the future of obesity treatment isn’t “either/or” but “both/and”
🔬 The Evolving Landscape of Obesity Treatment
For years, obesity treatment was seen as a choice between surgery or medication. But that black-and-white thinking is changing.
In this episode, Dr. Melissa Beitner, a bariatric surgeon and obesity medicine specialist at 360 Surgery, joins Jacqui Lewis to unpack the new, integrated approach — one that combines medical, surgical, and lifestyle tools to treat obesity as the chronic disease it truly is.
Dr. Beitner explains how the combination or sequence of treatments — medication → surgery or surgery → medication — can dramatically improve both short- and long-term results.
⚖️ Who Qualifies for Each Treatment?
Eligibility for either treatment depends on BMI and related health conditions, but the lines are shifting.
Traditionally, surgery was recommended for people with a BMI ≥ 40, or ≥ 35 with comorbidities such as diabetes or hypertension. Medications are often prescribed at lower BMIs or as an adjunct to lifestyle therapy.
Yet as research evolves, specialists like Dr. Beitner are re-evaluating these rigid thresholds — especially when a patient’s metabolic health or quality of life is at risk.
“We shouldn’t wait for weight regain or worsening comorbidities before intervening. The goal is sustained health, not just a smaller number on the scale.”
💊 When Medication Alone Isn’t Enough
GLP-1–based medications have revolutionized obesity care. They improve blood sugar control and reduce appetite, but they’re not a silver bullet.
Many patients experience weight plateaus or regain once medication stops. According to recent studies, most users regain up to two-thirds of their lost weight within a year of discontinuation (Rubino et al., 2023).
This is where bariatric surgery can play a complementary role — helping to maintain rather than merely initiate weight loss.
🏥 Bariatric Surgery as a Weight-Maintenance Strategy
Dr. Beitner references emerging international guidelines, including updates from IFSO (International Federation for the Surgery of Obesity), that now recognize bariatric surgery as a valid weight-maintenance strategy — not just a last resort.
She explains:
“Some patients who achieve initial results with medication may benefit from surgery to maintain them — especially if they can’t tolerate long-term medication or have unrealistic expectations of what medication alone can achieve.”
This approach reframes surgery from being a “final option” to an evidence-based tool for durability and metabolic stability.
🔁 The Dangers of Weight Cycling
Weight regain isn’t just discouraging — it’s metabolically damaging.
Dr. Beitner cites studies showing that animals (and people) who repeatedly lose and regain weight end up in worse metabolic health than those who remained at a stable higher weight. Each cycle also leads to muscle and bone loss, increasing frailty and reducing resting metabolism.
📌 Fact Check: Repeated weight cycling is associated with higher risks of insulin resistance, cardiovascular disease, and inflammation (Montani et al., 2015).
🧩 A Multidisciplinary Approach
At her Melbourne-based clinic 360 Surgery, Dr. Beitner leads a team of dietitians, psychologists, exercise physiologists, and physicians. Their integrated model ensures every patient receives individualized care — not a one-size-fits-all solution.
This holistic view acknowledges that obesity treatment isn’t about willpower. It’s about biology, environment, and consistent medical support.
“Treating obesity successfully means addressing the whole person — their metabolism, their mindset, and their long-term health.”
💰 Financial Considerations: Surgery vs. Ongoing Medications
Dr. Beitner also highlights a growing reality: cost matters.
Long-term use of newer obesity medications can add up to tens of thousands of dollars over several years, while bariatric surgery, though an upfront investment, is typically a one-time cost with durable results.
Patients and clinicians must weigh the financial, medical, and lifestyle implications of each path — ideally with transparent, evidence-based guidance.
🚀 The Future of Obesity Care
The next frontier of obesity treatment includes multi-agonist medications, endoscopic procedures, and improved surgical-pharmacologic combinations.
Dr. Beitner emphasizes that this is only the beginning:
“We’re entering an era where obesity treatment is integrated, dynamic, and deeply personalized. The key is collaboration, not competition, between medical and surgical approaches.”
🎧 Listen to the Full Episode
“The Truth About GLP-1 Medications and Bariatric Surgery”
🎙️ Hosted by Jacqui Lewis on the Australian Weight Loss Surgery Podcast
👉 Check Dr. Melissa Beitner here:
✨ Final Takeaway
Obesity treatment isn’t about choosing one path — it’s about finding the right combination. Whether through medication, surgery, or both, long-term success depends on treating obesity as the chronic, relapsing condition it is — with care that’s compassionate, science-based, and sustainable.
“The future isn’t medication vs. surgery — it’s medicine and surgery, working together.”
Sources:
-
Rubino D. M. et al. (2023). Discontinuation of GLP-1 therapy and weight regain. Obesity Journal.
-
Montani J. P. et al. (2015). Pathophysiology of weight cycling: Consequences for metabolic health. Physiology & Behavior.
-
IFSO (2022). Guidelines on metabolic and bariatric surgery indications and outcomes.
